Amplification of 19q is a frequent genetic alteration in many solid tumors, and SEI1 is a candidate oncogene within the amplified region. Our previous study found that the oncogenic function of SEI1 was associated with chromosome instability. In this study, we report a novel mechanism of genomic instability involving the SEI1-SET-NM23H1 pathway. Overexpression of SEI1 was observed in 57 of 100 of esophageal squamous cell carcinoma cases. Functional study showed that SEI1 had strong tumorigenic ability, and overexpression of SEI1 could induce the genomic instability by increasing micronuclei formation and reducing the number of chromosomes. Further study found that SEI1 was able to upregulate SET expression and subsequently promote the translocation of a small amount of NM23H1 from the cytoplasm to the nucleus. Nuclear NM23H1 can induce DNA damage through its DNA nick activity. Unlike CTL attack, only a small amount of NM23H1 translocated into the nucleus (<10%) induced by the overexpression of SEI1. Further study found that the small amount of NM23H1 only induced minor DNA damage and subsequently increased genomic instability, rather than inducing irreparable DNA damage and initiating apoptosis by CTL attack. Sister chromatid exchange experiment found that the translocation of small amount of NM23H1 into the nucleus induced by the overexpressions of SEI1/SET could increase the frequency of sister chromatid exchange. In addition, overexpression of SEI1 was associated with poor prognosis of esophageal squamous cell carcinoma. Taken together, these findings define a novel mechanism of genomic instability and malignant progression in esophageal cancers, a deadly disease of increasing incidence in developed countries. Cancer Res; 70(14); 5695-705. ©2010 AACR.
Introduction
Gene amplification is an important mechanism that affects oncogene expression in a variety of human cancers, which has been shown to play a key role in the pathogenesis of cancer. Identification of commonly amplified chromosomal regions and their corresponding overexpressed oncogenes within the regions is imperative to understand the molecular mechanism of cancer development. Amplification of 19q is one of the most frequent genetic alterations in many solid tumors including breast cancer (1, 2) , esophageal cancer (3, 4) , ovarian cancer (5, 6) , lung cancer (7) , and pancreatic cancer (8) . This suggests that 19q harbors one or more oncogenes associated with cancer development. Our previous study identified two overlapping minimal amplification regions in four ovarian cancer cell lines with amplification of 19q13.1 and several candidate oncogenes within the minimal amplification regions including SEI1 (9) .
The SEI1 gene product p34 SEI1 (also named SERTAD1 and TRIP-Br1) is a CDK4-binding protein that regulates cell cycle by modulating the kinase activity of the CDK4/Cyclin D/p16 and E2F-1/DP-1 complexes (10) (11) (12) . A recent study found that p34 SEI1 could inhibit apoptosis through the stabilization of the X-linked inhibitor of apoptosis protein (13) . Our previous study indicated that the oncogenic function of SEI1 was associated with chromosome instability (14) . Ectopic expression of SEI1 could markedly increase the frequencies of chromosomal alteration and micronulei formation. However, the molecular mechanism of SEI1 in chromosome instability remains obscure.
To explore the molecular mechanism of SEI1 in genomic instability, a tetracycline-induced SEI1 expression cell line was established using a breast cancer cell line MDA-MB-435 (15) . Proteomics was used to isolate differentially expressed proteins between SEI1-on and SEI1-off cells, and one upregulated protein in SEI1-on cells, SET, was characterized. SET is a nucleosome assembly protein that can bind NM23H1 and is associated with the translocation of NM23H1 from the cytoplasm to the nucleus (16) (17) (18) . NM23H1 is an evolutionarily conserved nucleoside diphosphate kinase and has DNA-nicking ability (19) . Once NM23H1 translocates from the cytoplasm to the nucleus, it may cause a minor DNA damage and subsequently induce chromosome instability by nicking DNA. The clinical significance of SEI1 was also addressed in esophageal squamous cell carcinoma (ESCC), and the result indicated that overexpression of SEI1 was significantly associated with the poor prognosis of ESCC.
Materials and Methods

Cell lines and ESCC specimens
The breast cancer cell line MDA-MB-435 was obtained from KeyGen Biotech Co. and cultured in DMEM/F12 with 10% fetal bovine serum (FBS). All ESCC cell lines used in this study have been previously described (20, 21) . The primary ESCC tumor tissues and paired nontumorous tissues were obtained from Linzhou Cancer Hospital. Tissue samples used in this study were approved by the Committees for Ethical Review of Research Involving Human Subjects at Zhengzhou University.
Establishment of inducible SEI1-expressing cell line
Full-length human SEI1 gene was cloned into the tetracyclineinducible vector pcDNA 4/TO (Invitrogen) and then transfected into MDA-MB-435 cells initially transfected with the vector pcDNA6/TR. Before the tetracycline-inducible vector pcDNA 4/TO containing SEI1 was transfected into MDA-MB-435 cells, pcDNA 4/TO containing GFP was transfected into MDA-MB-435 cells to select clones without visible leaking expression of tested gene. More than 100 clones were screened, and one clone without visible leaking expression of green fluorescent protein (GFP; Supplementary Fig. S1A ) was selected for further study. Tetracycline-induced SEI1-expressing cell lines (SEI1-on/off) were generated. To induce SEI1 expression, 1 μg/mL tetracycline was added into the culture medium. Reverse transcription-PCR (RT-PCR) and Western blot analysis were used to detect the expression of SEI1.
Tumorigenic function of SEI1
The tumorigenic function of SEI1 was studied by both in vitro and in vivo assays. Cell growth assay, soft agar assay, and foci formation assay were performed as previously described (21) . Triplicate independent assays were performed. The in vivo tumorigenic effect of SEI1 was investigated by xenograft mouse experiments as previously described (21) . Animal experiments were performed in compliance with the guidelines for the Welfare of Experimental Animals in Sun Yat-sen University. For the SEI1-on group (seven mice), tetracycline was added to the drinking water (5% sucrose and 2 g/L tetracycline). For the SEI1-off group (seven mice), only 5% sucrose was supplied. Mice were then examined for tumor growth by measuring tumor size over a period of 4 weeks.
Detection of micronuclei
Cells grown on coverslips were fixed and stained with 4′,6-diamidino-2-phenylindole. The number of cells with micronuclei was counted. For the analysis, 3,000 cells were examined for each sample. Data presented are the mean of three independent experiments.
Spectral karyotyping
The spectral karyotyping (SKY) analysis was performed as described (22) on long-term tetracycline-cultured cells SEI1-on (L) and SEI1-off cells. Briefly, metaphase spreads were prepared on glass slides, denatured, and hybridized with denatured SKY probes (SkyPaint mixture, Applied Spectral Imaging) at 37°C for ≥36 hours. At least 30 metaphase spreads from each cell line were analyzed.
Fluorescence in situ hybridization
DNA copy number of SEI1 in six ESCC cell lines (EC109, KYSE30, KYSE140, KYSE410, KYSE510, and KYSE520) was determined by fluorescence in situ hybridization (FISH) using a BAC clone (CTC-492K19) containing the SEI1 gene. The BAC probe and another BAC (RP11-565J3) probe that mapped to 19p13.3 were labeled with Spectrum-green-dUTP and Spectrum-orange-dUTP by nick translation (Vysis), respectively. The labeled probes were mixed, denatured, and hybridized to metaphase chromosomes from ESCC cells by FISH according to the method previously described (23) .
Two-dimensional gel electrophoresis and protein identification
Two-dimensional gel electrophoresis and mass spectrometry analyses were performed as previously described (24) . Only proteins with scores corresponding to P < 0.05 were considered. Furthermore, the molecular weight and isoelectric point of each protein identified by the database search were compared with the values obtained from the twodimensional gel electrophoresis patterns.
Western blot analysis
Western blot analyses were performed by a standard method with antibodies to SEI1 (Life span Biosciences), glyceraldehyde-3-phosphate dehydrogenase (GAPDH), NM23H1, and Calregulin (C-17; Santa Cruz Biotechnology). Secondary antibodies were horseradish peroxidase conjugated (Millipore).
Silencing SEI1 expression by RNA interference
Expression of SEI1 in SEI1-on cells was knocked down by RNA interference using small interfering RNAs (siRNA) against SEI1 as previously described (14) . Double-stranded siRNAs were transiently transfected into SEI1-on cells using Lipofectamine 2000 (Invitrogen) according to the manufacturer's instruction. Forty-eight hours after transfection, the extent of gene silencing was measured by real-time PCR.
CTL attack and cytoplasmic/nuclear protein extraction MDA-MB-435 cells were attacked by lymphokine-activated killer cell (LAK) as described (15) . LAK cells were generated from human peripheral blood mononuclear cells cultured for 14 days in RPMI 1640 with 10% FBS containing 1,000 IU/mL recombinant human interleukin 2 (R&D Systems). The ratio between LAK cells and target cells was 2:1 for fluorescenceactivated cell sorting (FACS) and 1:1 for immunoblot. The reactions were terminated at indicated times by washing cells with PBS. Cells were fixed and stained with propidium iodide and Annexin V, and analyzed by flow cytometry. Cytoplasmic proteins and nuclear proteins were separated using the NucBuster Protein Extraction kit (Novagen).
Flow cytometry analysis
At the indicated incubation time, cells were detached, washed with PBS, stained with Annexin V-FITC and propidium iodide, and immediately analyzed using a FACS flow cytometer (FACS Calibur BD Biosciences). For each measurement, 10,000 cells were counted. Triplicate independent assays were performed.
Tissue microarray and immunohistochemistry
Paraffin blocks from 300 patients with ESCC and paired nontumorous esophageal tissues were collected at Linzhou Cancer Hospital. The tissue microarray blocks were constructed according to the method previously described (25) . Immunohistochemistry (IHC) was performed using the standard streptavidin-biotin-peroxidase complex method. A 1:100 diluted polyclonal anti-SEI1 (Life span Biosciences) antibody was used for SEI1 detection. SEI1 expression was scored by combining the (a) proportion of positively stained cells (0, <5%; 1, 6-25%; 2, 26-50%; 3, 51-75%; 4, >75%) and (b) the intensity of staining (0, negative staining; 1, mild staining; 2, moderate staining; 3, strong staining). The score was measured as a × b, and the result was defined as negative (0 point), weakly positive (1-3 points), moderately positive (4-7 points), and strongly positive (8-12 points).
Sister chromatid exchange assay
A bromodeoxyuridine (BrdUrd) solution at a final concentration of 10 mg/mL was added to the culture medium of SEI1-on (L) and SEI1-off cells. Cells were cultured for 48 hours and blocked at metaphase during the last 3 hours with colcemid at 0.08 μg/mL. Metaphase spreads were prepared on slides and stained with fluorescein plus Giemsa staining for the detection of sister chromatid exchange (SCE; ref. 26 ).
Statistical analysis
Results are reported as means ± SEM. Data were compared by one-way ANOVA with post hoc assessment for least significant difference. The RT-PCR result of clinical samples and tissue microarray data were processed by the SPSS statistical package for Window version 16 (SPSS, Inc.). Survival curves were generated according to the Kaplan-Meier method, and statistical analysis was performed by log-rank test. P < 0.05 was accepted as statistically significant.
Results
Establishment of an inducible SEI1 expression cell line
The full-length SEI1 gene was cloned into a tetracyclineinducible vector pcDNA 4/TO and stably transfected into MDA-MB-435 cells. After selection, one tetracycline-inducible SEI1 expression cell line (SEI1-on/off) was successfully established. Expression of SEI1 could be effectively induced by tetracycline in a dose-dependent manner ( Supplementary  Fig. S1B ). The expression level of SEI1 in SEI1-on cells was very stable when SEI1 was turned on for 3 months (Fig. 1A) . The expression of SEI1 was also confirmed by Western blot analysis (Fig. 1A) .
Oncogenic function of SEI1
The oncogenic function of SEI1 was investigated in the SEI1-on/off cell line by both in vitro and in vivo assays. Cell growth assay showed that the cell growth rate was significantly higher in SEI1-on cells (P < 0.05) than that in SEI1-off cells (Fig. 1B) . Soft agar assay showed that the frequency of colony formation in soft agar was significantly higher in SEI1-on cells (P < 0.01) than that in SEI1-off cells (Fig. 1C) . Similarly, the results from cell proliferation assay showed that the frequency of foci formation was also significantly higher in SEI1-on cells (P < 0.05) than that in SEI1-off cells (Supplementary Fig. S1C ). Two weeks after the injection of SEI1-on/off cells into nude mice (palpable tumor had formed), tetracycline was given to one of the two tested mice (each group had seven mice). Tumor formation was observed in all 14 tested mice. However, the tumor growth rate was significantly increased in the mice that were fed with tetracycline (P < 0.05; Fig. 1D ). These results indicated that SEI1 had strong tumorigenic ability.
SEI1 induces chromosome instability
Micronuclei formation, which contains unstable extranucleus chromosomal fragments caused by chromosome rearrangement (27) , was used to compare the frequencies of micronuclei formation between SEI1-on and SEI1-off cells. When SEI1 expression was induced by tetracycline, the formation of micronuclei was significantly increased (14.88 ± 0.62%) compared with that of SEI1-off cells (10.06 ± 0.43%) and parental cells (8.23 ± 0.38%, P < 0.05; Fig. 2A ). Three months after SEI1 was turned on, cytogenetic analysis was used to compare both numerical and structural chromosomal alterations between SEI1-on (long term) and SEI1-off cells. In SEI1-off cells (n = 500), the numbers of chromosomes ranged from 48 to 52 (Fig. 2B) , and the most predominant numbers were 50 (n = 315, 63%) and 51 (n = 105, 21%). In SEI1-on cells (n = 500), the numbers of chromosomes ranged from 34 to 52 (Fig. 2B) , and loss of chromosomes (chromosome number, <48) was observed in 25% (n = 125) of the cells. In addition, some rearranged chromosomes, such as small ring chromosome, could be only detected in SEI1-on cells (Fig. 2C) . The loss of chromosomes in SEI1-on cells was also confirmed by SKY analysis (Supplementary Fig. S2 ).
To further confirm that SEI1 overexpression also induces genomic instability in ESCC, micronucleus formation assay was performed in three ESCC cell lines (KYSE30, KYSE140, and KYSE180). The results showed that introduction of SEI1 into these cell lines could significantly (P < 0.001, t test) increase the frequency of micronuclei formation (Fig. 2D) , suggesting that SEI1 overexpression also plays an important role in ESCC development by increasing genomic instability.
Amplification and overexpression of SEI1 in ESCC
Because amplification of 19q has been found to be frequently detected in esophageal cancer (3, 4) , amplification of SEI1 gene in ESCC cell lines and the overexpression of SEI1 in primary ESCC cases were investigated. Gain of the DNA copy number of SEI1 was detected in three of six ESCC cell lines (KYSE140, KYSE410, and KYSE510), compared with signals at 19p (Supplementary Fig. S3A ). A homogeneously staining region containing the SEI1 gene was observed in KYSE510. Expression of SEI1 between tumor and nontumorous tissues in 100 pairs of primary ESCC was compared by RT-PCR. The results showed that overexpression of SEI1 was detected in 57 of 100 (57%) of ESCCs ( Supplementary Fig. S3B ).
Identification of SEI1 correlated proteins by proteomics
To explore the mechanism of SEI1 in cancer development, proteomics was used to identify differentially expressed proteins between SEI1-on and SEI1-off cells. Twenty-seven differentially expressed proteins were identified by Mass Spec (Supplementary Table S1 ), including SET ( Supplementary  Fig. S4 ). Overexpression of SET in SEI1-on cells was confirmed by Western blot analysis (Fig. 3A) .
SEI1 upregulates SET expression
The correlation of SET expression with SEI1 was analyzed by quantitative real-time PCR. Two hours after SEI1 was turned on, expressions of both SEI1 and SET were increased, and expression level of SET was significantly higher in the cells that had SEI1 turned on than that in the SEI1-off cells (P < 0.01; Fig. 3A) . The correlation of SET expression with SEI1 was also studied in an ESCC cell line KYSE140. After transient transfection of SEI1, expressions of both SEI1 and SET were significantly increased (P < 0.01; Fig. 3B ) detected by both Western blot analysis and qPCR. To further confirm the correlation between SEI1 and SET, RNA interference was used to silence SEI1 expression using siRNA against SEI1. The results showed that the expression of SET was significantly downregulated (P < 0.05) when SEI1 was silenced by siRNA-SEI1 compared with control siRNA (Fig. 3C) . The correlation Overexpression of SEI1 increases genomic instability. A, the frequency of micronucleus formation was significantly increased in SEI1-on (long term) cells, compared with SEI1-off cells and parental cells (left). Three thousand cells were studied for each cell line. Right, the representative images of micronuclei formation in SEI1-on and SEI1-off cells. B, distribution of chromosome numbers was compared between SEI1-on and SEI1-off cells by cytogenetic analysis. Chromosome instability was characterized as loss of chromosomes, which was markedly increased in SEI1-on cells. Five hundred cells were characterized for each cell line. C, representatives of karyotypes from SEI1-on and SEI1-off cells. Some de novo unknown markers were detected in SEI1-on cells (arrow). D, the frequency of micronucleus formation was compared between parental cells and cells transfected with SEI1 in three ESCC cell lines. Three thousand cells were studied for each cell line. **, P < 0.001.
of expressions between SEI1 and SET was also studied in 100 clinical ESCC specimens. A significant association of expression level between SEI1 and SET was observed (P < 0.01; Fig. 3D ). All these data strongly indicated that SEI1 could upregulate SET expression.
SET is associated with the cytoplasm-to-nucleus translocation of NM23H1
Previous reports have revealed that SET can bind to NM23H1 and associated with the translocation of NM23H1 from the cytoplasm to the nucleus (16) (17) (18) . In the present study, the association of the cytoplasm-to-nucleus translocation of NM23H1 with upregulation of SET was addressed. The protein levels of SET and NM23H1 in the cytosolic and nuclear fractions were compared by Western blot analysis between SEI1-on (2 h or overnight) and SEI1-off cells. The results showed that~10% of SET and <10% of NM23H1 translocated from cytoplasm to nucleus after SEI1 was turned on (Fig. 4A) . The protein level of NM23H1 in the nuclear fraction showed no obvious alteration in the amount of protein between 2 and 12 hours.
Fan and colleagues (16) reported that SET and NM23H1 were translocated into the nucleus after Granzyme A loading or CTL attack, allowing NM23H1 to nick chromosomal DNA and induce a caspase-independent cell death pathway. In this study, we also studied the cytoplasm-tonucleus translocation of NM23H1 under the CTL attack. LAK cells from a normal donor were used to attack MDA-MB-435 cells, and the amount of NM23H1 in the cytosolic and nuclear fractions was determined by Western blot analysis. About 60% of NM23H1 was translocated from the cytoplasm to the nucleus 30 minutes after CTL attack (Fig. 4B) . One hour after CTL attack, >50% cells underwent cell death and >70% of NM23H1 has been translocated from the cytoplasm to the nucleus in the viable cell population (Fig. 4B) .
Cytoplasm-to-nucleus translocation of NM23H1 induces apoptosis
Consistent with that reported by Fan and colleagues (16) , a large amount (>60%) translocation of NM23H1 into nucleus could cause irreparable DNA damage and induce apoptosis 30 minutes after CTL attack (Fig. 4C) . Almost all cells underwent cell death 2 hours after CTL attack. Interestingly, only a small amount of NM23H1 (<10%) translocated into the nucleus after increased expression of SET, which only elevated apoptotic index slightly (Fig. 4D) . . GAPDH was used as a loading control. SEI1 upregulates SET expression as detected by quantitative real-time PCR (right). After SEI1 was turned on, expression of SET was significantly upregulated. Columns, mean of three independent experiments; bars, SD. **, P < 0.01. B, when SEI1 was transiently transfected into KYSE140 cells, expression of SET was significantly upregulated detected by Western blot analysis (WB; left) and quantitative real-time PCR (qPCR; right). Columns, mean of three independent experiments; bars, SD. **, P < 0.01. C, siRNA against SEI1 reduces SEI1 expression and downregulates SET expression. siRNA against GFP was used as control. Expressions of SEI1 and SET were determined by qPCR (left) and Western blot analysis (right). Columns, mean of three independent experiments; bars, SD. **, P < 0.05. D, correlation between the expression level of SEI1 and SET in 100 ESCCs, with a linear regression line and a significant correlation (P < 0.01).
Small amount of NM23H1 increases chromosome instability
Based on the observation that a low level of translocation of NM23H1 into the nucleus did not induce apoptosis in most cells, we hypothesized that the small amount of NM23H1 in the nucleus could cause minor DNA damage by its DNA-nicking activity and lead to chromosome instability by increasing the frequency of SCE. To address this question, SCE assay was used to compare the SCE frequency between SEI1-on (3 mo) and SEI1-off cells (50 metaphases for each type of cells). The results showed that the frequency of SCE in SEI1-on cells was significantly higher (7.84%) than that of SEI1-off cells (2.68%, P < 0.001; Fig. 5A ), suggesting that a small amount of NM23H1 could increase chromosome instability.
Overexpression of SEI1 is associated with poor prognosis of ESCC
To explore the clinical significance of SEI1 overexpression in ESCC, SEI1 expression status and its association with clinicopathologic features were examined by IHC using an ESCC tissue microarray containing 300 pairs of ESCC and matched nontumorous esophageal specimens. Informative IHC results were obtained from 167 (55.7%) of nontumorous esophageal tissues and 213 (71%) of ESCCs, respectively. Noninformative samples included lost samples, unrepresentative samples, samples with too few tumor cells, and samples with inappropriate staining. The IHC analysis showed that absent and very weak expression of SEI1 was detected in 142 of 167 (85%) of nontumorous tissues. Moderate and strong expression of SEI1 was detected in 164 of 213 (77%) of ESCC specimens (Fig. 5B) . Informative data from both tumor and paired nontumorous specimens were observed in 124 cases, and increased expression of SEI1 in tumor tissues was detected in 105 (84.7%) cases.
The association study showed that SEI1 overexpression was significantly associated with depth of tumor infiltration (P = 0.017), T stage (P = 0.007), and clinical stage (P = 0.023) of ESCC (Table 1) . Kaplan-Meier analysis was used to study the survival curves in 124 ESCC patients with survival data. The result suggested that the overexpression of SEI1 was significantly associated with the poor outcome of ESCC patients (log-rank P < 0.05; Fig. 5C ). Figure 4 . Western blotting showed that only a small amount of NM23H1 was translocated from the cytoplasm to the nucleus after SEI1 was turned on (A), whereas a large amount of NM23H1 was translocated from the cytoplasm to the nucleus after CTL attack (B); C, cytosolic fraction; N, nuclear fraction. Calregulin was used as a cytosolic protein control. The percentage of apoptotic cells was determined by flow cytometry in cells attacked by CTL (C) or with SEI1 expression (D). Points, mean of three independent experiments; bars, SD.
Discussion
Genomic instability is one of the major causes of cancer development, which can be induced by many factors including centrosome-associated kinases and abnormalities in cell cycle control genes (28) . For example, overexpression of Aurora-A, a centrosome-associated kinase, can induce genetic instability as characterized by centrosome amplification, chromosome tetraploidization, and premature sister chromatid segregation (29) . In our previous study, we found that the oncogenic role of SEI1 was associated with its effect on chromosomal instability (14) . However, the molecular mechanism of how SEI1 induces genomic instability remains unclear. To address this question, a tetracycline-inducible SEI1-expressing cell line was established using a breast cancer cell line MDA-MB-435. After this cell line was generated, the oncogenic function of SEI1 was confirmed by both in vitro and in vivo assays when the expression of SEI1 was induced by the addition of tetracycline into the culture medium. We next investigated whether the oncogenic function of SEI1 in MDA-MB-435 cells was associated with genomic instability using cytogenetic analysis and quantification of micronuclei formation, an indicator of genomic instability (30) . The results showed that the micronuclei formation in SEI1-on cells Figure 5 . A, representatives of two metaphase spreads harvested from SEI1-off (left) and SEI1-on (right) cells. After BrdUrd-incorporated, metaphase spreads were prepared and stained with fluorescein plus Giemsa, the images were captured. Arrows, SCE. B, examples of SEI1 expression detected by IHC in two pairs of ESCC tumor tissues and matched normal esophageal tissues (×400 magnification). C, Kaplan-Meier analysis shows that overexpression of SEI1 was significantly associated with poor overall survival in 124 ESCC cases.
(14.88%) was significantly higher than that in SEI1-off cells (10.06, P < 0.05). Interestingly, both cytogenetic and SKY analyses found that the number of chromosomes decreased when SEI1 was turned on for 3 months.
Because amplification of 19q was frequently detected in esophageal carcinoma (3, 4) , the expression status of SEI1 in ESCC was investigated in the present study. The results showed that overexpression of SEI1 RNA and protein levels were detected in 57 of 100 (57%) and 164 of 213 (77%) of ESCC specimens, respectively. In addition, a gain of the SEI1 alleles was observed in three of six of the ESCC cell lines. These data strongly suggest that overexpression of SEI1 might play an important role in the development and progression of ESCC. To further reveal the molecular mechanism of genomic instability of SEI1, two-dimensional gel electrophoresis was used to compare differentially expressed proteins between SEI1-on and SEI1-off cells. Several differentially expressed proteins were identified including SET. SET (also known as PHAPII, TAF-1β, and IB 2B PP2A) was first identified as a translocated gene that was fused to the CAN gene in a patient with acute undifferentiated leukemia (31) . In the present study, we showed that the expression of SET could be upregulated by SEI1 in SEI1-on/off cells and SEI1-transfected KYSE140 cells.
When the expression of SEI1 was knocked down by siRNA, the expression of SET was also decreased. One of the known functions of SET is to interact with NM23H1 in mediating the granzyme A-triggered, caspase-independent cell death pathway (16) . After CTL attack or granzyme A loading, SET binds to NM23H1 and translocates to the nucleus. When SET is degraded inside the nucleus, NM23H1 is released and damages DNA by nicking chromosomal DNA.
NM23H1 belongs to the NM23 gene family, which contains eight human members (32) . Nm23H1 is expressed in several types of tumors and has been associated with reduced metastatic potential in several malignancies (33, 34) . NM23H1 possesses nucleoside diphosphate kinase activity, whereby it catalyzes the transfer of γ-phosphates between nucleotide triphosphates and nucleotide diphosphates (35) . Biochemical studies show that NM23H1 has other functions, in addition to its role as a nucleoside diphosphate kinase, which includes DNA cleavage activity (36) . NM23H1 is able to recognize the 5′-SHS silencer and the NHE basal promoter of PDGF-A as substrates for DNA nicking (19) . Furthermore, NM23H1 is a 3′-5′ exonuclease by its ability to excise single nucleotides in a stepwise manner from the 3′ terminus of DNA (37) . Therefore, we hypothesize that overexpression of SEI1 is able to upregulate SET expression, and it subsequently increases SET-NM23H1 binding and induces the translocation of a small amount of NM23H1 from the cytoplasm to the nucleus through an unidentified mechanism. When NM23H1 is released in the nucleus, it causes DNA damage by excising single nucleotides. Under CTL attack, a large amount of NM23H1 enters the nucleus in a short amount of time and causes irreversible DNA damage and subsequently triggers apoptosis. However, overexpression of SEI1 can only induces a small amount of NM23H1 translocation from the cytoplasm into the nucleus and cause minor DNA damage, which increases chromosome instability rather than inducing apoptosis.
To test our hypothesis, the amount of NM23H1 translocated from cytoplasm to nucleus was compared between cells with SEI1 overexpression and cells attacked by CTL. As expected, a large amount of NM23H1 (∼60% at 30 min and 70% at 1 h) was translocated from the cytoplasm to the nucleus, whereas only a small amount of NM23H1 (<10%) was translocated into the nucleus 12 hours after SEI1 was turned on. We next investigated the effect of NM23H1 translocation on apoptosis. Consistent with previous findings, apoptosis could be detected in ∼45% cells 30 minutes after CTL attack and almost all cells were dead 2 hours after the attack. In SEI1-on cells, the apoptotic index was only slightly increased from approximately 10% to 25% 12 hours after SEI1 was turned on. These results suggested that the DNA damage caused by the SEI1/SET/NM23H1 pathway was minor and apoptosis occurred in only small proportion of cells. To further confirm that overexpression of SEI1 could induce minor DNA damage and increase chromosomal instability, SCE was used to compare the SCE frequency between SEI1-on and SEI1-off cells. The results showed that the frequency of SCE in SEI1-on cells was significantly higher (7.84%) than that of SEI1-off cells (2.68%, P < 0.001), suggesting that the translocation of small amount NM23H1 induced by SEI1 overexpression could induce a minor DNA damage and increase chromosome instability. In this study, we also showed that the ectopic expression of SEI1 could upregulate SET expression and induce genomic instability by increasing the frequency of micronuclei formation. The clinical significance of SEI1 overexpression in ESCC was also studied in this study using tissue microarray containing 300 pairs of ESCC and nontumorous esophageal specimens. The results showed that SEI1 overexpression was significantly associated with depth of tumor infiltration, T stage, and clinical stage of ESCC. Kaplan-Meier analysis found that SEI1 overexpression was significantly associated with the poor outcome of ESCC patients. In summary, our study reveals that SEI1 can upregulate SET expression, which induces NM23H1 translocation from cytoplasm to nucleus and causes minor DNA damage by nicking DNA, and subsequently increases chromosome instability. Further characterization of this novel mechanism of genomic instability will greatly facilitate our understanding on genomic instability and find novel therapeutic targets for cancer treatment.
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